Science & Research

2015 Science Writers Symposium: Agenda

FRIDAY, SEPTEMBER 18, 2015, 9 AM TO 5 PM ET 

OPENING REMARKS
Luciana Borio, M.D., Acting Chief Scientist
 
SESSION 1
The mysterious resurgence of mumps and pertussis—and our work to prevent new epidemics
Tod Merkel, Ph.D., Principal Investigator, Laboratory of Respiratory and Special Pathogens, Center for Biologics Evaluation and Research
Steven Rubin, Ph.D., Acting Chief, Laboratory of Method Development, Center for Biologics Evaluation and Research

SESSION 2
Investigating the early detection of traumatic brain injury
Cristin Welle, Ph.D., Neuroscientist, Center for Devices and Radiological Health
Meijun Ye, Ph.D., Postdoctoral Fellow, Center for Devices and Radiological Health
 
SESSION 3
The many applications of 3D printing
Matthew Di Prima, Ph.D., Materials Scientist, Center for Devices and Radiological Health
 
SESSION 4
Panel: How computational modeling and simulation can revolutionize medical product development
Moderator: Karen Riley, M.P.H., Deputy Director for Strategy, Office of External Affairs
Naomi L. Kruhlak, Ph.D., Lead, Chemical Informatics Program, Center for Drug Evaluation and Research
Bill Mattes, Ph.D., Director of the Division of System Biology, National Center for Toxicological Research
Tina M. Morrison, Ph.D., Regulatory Advisor of Computational Modeling, Center for Devices and Radiological Health
 
SESSION 5
Research in the field
Brian L. Baker, M.S., M.S., P.E., Director, Winchester Engineering and Analytical Center, Office of Regulatory Affairs
Patrick Regan, Ph.D., Analytical Branch Director, Winchester Engineering and Analytical Center, Office of Regulatory Affairs 

SESSION 6
Developing tools to keep dengue and chikungunya viruses out of our blood supply
Maria Rios, Ph.D., Senior Scientist, Center for Biologics Evaluation and Research
 
SESSION 7
A word with the Acting Commissioner and special guests
Featured speaker: Stephen Ostroff, M.D., Acting Commissioner 
Guest speaker: Maria Freire, Ph.D., President of the Foundation for the National Institutes of Health and Chairman of the FDA’s Science Board
Guest speaker: Jane Reese-Coulbourne, M.S. ChE., Executive Director of the Reagan-Udall Foundation.
The speakers will discuss the current state of science at the FDA and the recommendations included in the new report Mission Possible: How FDA Can Move at the Speed of Science that was released this week by the FDA’s Science Board. 

BROWN BAG TALKS
 
The social science of tobacco use
Conrad Choiniere, Ph.D., Director, Division of Population Health Sciences, Office of Science, Center for Tobacco Products 

Our commitment to research: past to present
Suzanne Junod, Ph.D., Historian, Office of External Affairs
John P. Swann, Ph.D., Historian, Office of External Affairs
 
How innovative research inspires agency inventions
Alice Welch, Ph.D., Director, FDA Technology Transfer Program, Office of the Chief Scientist
 
SESSION 8
Panel: The science of patient input
Sara Eggers, Ph.D., Operations Research Analyst, Office of Strategic Programs, Center for Drug Evaluation and Research
CAPT Beth F. Fritsch, R.Ph., M.B.A., Deputy Director, Office of Health and Constituent Affairs
Kathryn M. O'Callaghan, Acting Associate Center Director for Science and Strategic Partnerships, Center for Devices and Radiological Health
Elektra J. Papadopoulos, M.D., M.P.H., Acting Associate Director Clinical Outcome Assessments Staff, Office of New Drugs, Center for Drug Evaluation and Research

SESSION 9
Lab tours
Stops within the Center for Devices and Radiological Health (CDRH) included visits to labs devoted to precision medicine focusing on research with patient-derived stem cells generated from an FDA-sponsored clinical trial (led by Ksenia Blinova, Ph.D., Staff Fellow, CDRH, and David Strauss, M.D., Ph.D., Senior Advisor for Translational and Experimental Medicine, Center for Drug Evaluation and Research); the evaluation of safety and effectiveness for digital pathology systems (led by Brandon Gallas, Ph.D., Research Physicist, CDRH); and improving functional device performance for existing and emerging medical device technologies (led by Gene Civillico, Ph.D., Health Physicist, CDRH). 

Stops within the Center for Biologics Evaluation and Research (CBER) included visits to labs devoted to stem cell research and flow cytometry (led by Steven R. Bauer, Ph.D., Chief, Cellular and Tissue Therapies Branch, CBER); Ebola research (led by Gerardo Kaplan, Ph.D., Principal Investigator at the Lab of Emerging Pathogens, CBER); computer technology called High-Performance Integrated Virtual Environment (HIVE), which supports FDA’s work on Next-Generation-Sequencing (led by Vahan Simonyan, Ph.D., Lead Scientist, HIVE, CBER); and nuclear magnetic resonance (led by Daron I. Freedberg, Ph.D., Principal Investigator, CBER). 

Page Last Updated: 09/23/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English